These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 17300858

  • 1. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL, McIntyre PB.
    Vaccine; 2007 May 04; 25(18):3574-80. PubMed ID: 17300858
    [Abstract] [Full Text] [Related]

  • 2. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.
    Kelly HA, Gidding HF, Karapanagiotidis T, Leydon JA, Riddell MA.
    BMC Public Health; 2007 Jun 08; 7():99. PubMed ID: 17555601
    [Abstract] [Full Text] [Related]

  • 3. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL.
    J Microbiol Immunol Infect; 2005 Jun 08; 38(3):169-75. PubMed ID: 15986066
    [Abstract] [Full Text] [Related]

  • 4. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS, Nokes DJ.
    Bull World Health Organ; 2001 Jun 08; 79(7):615-24. PubMed ID: 11477964
    [Abstract] [Full Text] [Related]

  • 5. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS, Han HW, Go U, Chung HW.
    Vaccine; 2004 Dec 02; 23(3):290-7. PubMed ID: 15530670
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune response to measles vaccine after mass vaccination in Urmia, Islamic Republic of Iran.
    Yekta Z, Pourali R, Taravati MR, Shahabi S, Salary S, Khalily F, Farzin A.
    East Mediterr Health J; 2009 Dec 02; 15(3):516-25. PubMed ID: 19731767
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progress toward measles and rubella elimination in Egypt.
    El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP, Naouri B, Reef SE.
    J Infect Dis; 2011 Jul 02; 204 Suppl 1():S318-24. PubMed ID: 21666180
    [Abstract] [Full Text] [Related]

  • 14. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults.
    Cohn ML, Robinson ED, Faerber M, Thomas D, Geyer S, Peters S, Martin M, Martin A, Sobel D, Jones R.
    Pediatr Infect Dis J; 1994 Jan 02; 13(1):34-8. PubMed ID: 8170730
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 02; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A, Torner N, Martínez A, Costa J, Plans P, Ciruela P, Salleras L.
    Vaccine; 2006 Feb 27; 24(9):1433-7. PubMed ID: 16226357
    [Abstract] [Full Text] [Related]

  • 20. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI, Nakamura MA, Godoy MV, Kuri P, Lucas CA, Conyer RT.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.